Clinical significance of HOXB4 gene expression levels in myelodysplastic syndromes
10.3969/j.issn.1006-5725.2024.03.007
- VernacularTitle:HOXB4基因表达水平在骨髓增生异常综合征中的临床意义
- Author:
Yichen WANG
1
,
2
;
Yanwen YAN
;
Meihui SONG
;
Xiangjun XUE
;
Wenguang ZHOU
;
Yuquan LI
;
Ling QI
;
Guanghua LI
;
Xiangzong ZENG
Author Information
1. 大理大学基础医学院(云南大理 671000)
2. 广州医科大学附属第六医院,清远市人民医院 消化病研究所(广东清远 511518)
- Keywords:
myelodysplastic syndrome;
HOXB4;
prognosis;
leukemia transformation
- From:
The Journal of Practical Medicine
2024;40(3):321-325
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of HOXB4 gene in patients with myelodysplastic syn-dromes(MDS)and its clinical significance in disease progression.Methods mRNA expression of HOXB4 gene in bone marrow mononuclear cells was detected by real-time fluorescence quantitative PCR(RT-qPCR),and the difference in HOXB4 expression was compared between 49 patients with MDS(MDS group)and 35 patients without MDS(group C).The relationship of mRNA expression of HOXB4 with disease characteristics and clinical prognosis was explored in MDS patients.Results mRNA expression level of HOXB4 gene was higher in MDS group than that in group C(P＜0.05).The patients were divided into a high-and a low-expression group according to the median expression level of HOXB4.Leukocyte count was lower in the high-expression group in the low-expression group at the time of initial diagnosis.The proportion of patients with subtypes of primitive cellular hyperplasia,poor prognostic staging and leukemic transformation was higher in the high-expression group than in the low-expression group.Conclusions mRNA expression level of HOXB4 gene has certain relation with AML transformation in MDS patients.
